Andrew King
Keine laufenden Positionen mehr
Profil
Andrew King worked as a Senior Director of Discovery & Translational Biology at Ardelyx, Inc. He then served as the Chief Scientific Officer at Chinook Therapeutics, Inc. from 2021 to 2023.
Dr. King holds a doctorate degree from Michigan State University and an undergraduate degree from Murdoch University.
Ehemalige bekannte Positionen von Andrew King
| Unternehmen | Position | Ende |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 09.08.2023 |
| ARDELYX, INC. | Corporate Officer/Principal | - |
Ausbildung von Andrew King
| Murdoch University | Undergraduate Degree |
| Michigan State University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARDELYX, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
